-
Pharma company acquires startup Oculeve for $125m (USD), including a novel nasal device for dry eye disease
-
Appraisal body calls for more information from drug company before issuing final guidance to NHS on dry eye treatment
-
New market report predicts growth will be driven by the launch of a number of new drugs and fixed-dose combinations
-
US study shows that standard 2g/day dose of metformin could potentially reduce the risk of open-angle glaucoma in diabetic patients by more than 20%
-
Early findings from phase II trials show positive results in treating optic neuritis, which may affect half of patients with multiple sclerosis
-
Evidence has emerged that Novartis may have launched a sustained campaign to block the off label use of cancer drug Avastin over its licensed treatment, Lucentis
-
US biohackers have reportedly boosted the dim-light vision of a test subject enabling him to better identify objects in a darkened environment
-
Clinical commissioning group (CCG) has cancelled plans to switch to Avastin for AMD patients, despite potential NHS savings of more than £100m a year
-
The heads of 120 CCGs have renewed calls to remove the barriers to practitioners using the cheaper drug for patients with wet AMD